Inactive Instrument

EVIO, Inc. Stock Other OTC

EVIO

US30051V1061

EVIO, Inc. is a diversified holding company. The Company provides analytical testing services to the agricultural and pharmaceutical industries, primarily for cannabis, hemp, and related products. The Company offers residential and commercial construction services. The Company also offers research and development and consulting services for participants in the cannabis and hemp industries. The Company tests products to verify the regulatory requirements for sale. Its subsidiaries include Smith Scientific Industries, LLC; Greenhaus Analytical Labs, LLC; Viridis Analytics, LLC; EVIO Labs OR, Inc.; C3 Labs, LLC; EVIO Labs Humboldt, LLC and Keystone Labs, Inc.

Employees

Sector

Business Support Services

More about the company

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	1.66M 1.46M 1.38M 1.26M 2.36M 159M 2.38M 16.56M 6.39M 81.35M 6.23M 6.1M 261M	P/E 2020	-0.08x	P/E 2021	-1.33x
Enterprise Value	14.32M 12.63M 11.94M 10.83M 20.32M 1.37B 20.5M 143M 55.1M 702M 53.78M 52.6M 2.25B	EV / Sales 2020	4.41x	EV / Sales 2021	6.54x
Free-Float	88.19%	Yield 2020 *	-	Yield 2021	-

22-03-10	DigiPath, Inc. cancelled the acquisition of a controlling stake in C3 Labs, LLC from EVIO, Inc..	CI
22-01-04	EVIO, Inc. Announces Partnership with Rare Earth Genomics Texas, LLC	CI
21-12-06	DigiPath, Inc. signed letter of intent to acquire a controlling stake in C3 Labs, LLC from EVIO, Inc..	CI
21-11-10	Framework announced that it has received $2 million in funding from EVIO, Inc., Atomico Investment Holdings Limited, Ada Ventures Limited, Learn Capital, LLC, and other investors	CI
21-11-02	EVIO, Inc. Announces Diversification into Blockchain	CI
21-07-11	EVIO, Inc. entered into a letter of intent to acquire Leading Edge Pharms, Inc.	CI
21-02-03	EVIO, Inc. announced that it has received $0.157 million in funding	CI
21-01-04	EVIO, Inc. Announces Executive Changes	CI
21-01-04	EVIO, Inc. Announces Executive Changes	CI
20-09-29	Steep Hill, Inc. completed the acquisition of unknown minority stake in C3 Labs, LLC from EVIO, Inc..	CI
20-09-09	Evio, Inc. Reports Earnings Results for the Third Quarter Ended June 30, 2020	CI
20-07-10	EVIO, Inc. Announces Executive Changes	CI
20-07-05	Steep Hill Labs, Inc. entered into non-binding Letter of Intent to acquire 49% stake in C3 Labs, LLC from EVIO, Inc..	CI

22-01-04	EVIO, Inc. Announces Partnership with Rare Earth Genomics Texas, LLC	PR
21-11-29	EVIO, Inc. Announces Major Blockchain Partnership with Chroma Signet	PR
21-11-02	EVIO, Inc. Announces Diversification into Blockchain	PR
21-10-15	EVIO, Inc :. provides Shareholder Update	PR
21-08-31	EVIO : Files Form 15 to Suspend SEC Reporting Requirements and Applies to Qualify for OTC Markets Alternative Reporting Standard for Pink Sheet Companies	PR

Manager	Title	Age	Since
William Waldrop CEO	Chief Executive Officer	58	-
Lori Glauser CEO	Chief Executive Officer	56	2020-12-31
Jeremy L. Sackett CTO	Chief Tech/Sci/R&D Officer	-	2021-05-12

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
EVIO, INC.	-3.45%	-6.67%	-	-	20.73K
SGS SA	+0.25%	-0.13%	+16.49%	+24.55%	22.36B
UL SOLUTIONS INC.	+0.19%	-2.11%	-6.51%	-	13.08B
CENTRE TESTING INTERNATIONAL GROUP CO. LTD.	-1.23%	-7.23%	+7.08%	-27.14%	3.45B
HEFEI CHIPMORE TECHNOLOGY CO.,LTD.	+3.17%	-7.98%	+36.04%	+46.43%	3.11B
TIC SOLUTIONS, INC.	-3.09%	-8.44%	-41.61%	-	1.91B
CHINA AUTOMOTIVE ENGINEERING RESEARCH INSTITUTE CO., LTD.	+0.39%	+0.15%	-26.63%	-35.65%	1.94B
GRG METROLOGY & TEST GROUP CO., LTD.	-2.00%	+2.62%	-5.46%	+18.46%	1.65B
EMTEK (SHENZHEN) CO., LTD.	+2.05%	-3.61%	+81.18%	+115.18%	1.52B
CHINA NATIONAL ELECTRIC APPARATUS RESEARCH INSTITUTE CO., LTD.	+0.69%	-0.95%	-26.64%	+6.08%	1.3B
Average	-0.30%	-2.62%	+3.77%	+21.13%	5.59B
Weighted average by Cap.	+0.18%	-1.47%	+7.32%	+21.05%

EVIO, Inc. Stock Other OTC

Stocks

EVIO

US30051V1061

Business Support Services

Valuation: EVIO, Inc.

Latest news: EVIO, Inc.

Press Releases: EVIO, Inc.

Quotes and Performance

Managers and Directors: EVIO, Inc.

Testing Laboratories

Financials

Company Profile

	2020	2021
Net sales	3.6M 3.17M 3M 2.72M 5.1M 345M 5.15M 35.87M 13.83M 176M 13.5M 13.21M 566M	2.36M 2.08M 1.97M 1.79M 3.35M 227M 3.38M 23.57M 9.09M 116M 8.87M 8.68M 372M
Net income	-8.42M -7.42M -7.02M -6.36M -11.94M -808M -12.05M -83.94M -32.38M -412M -31.6M -30.91M -1.32B	-965K -851K -804K -729K -1.37M -92.61M -1.38M -9.63M -3.71M -47.28M -3.62M -3.54M -152M
Net Debt	14.79M 13.04M 12.33M 11.18M 20.99M 1.42B 21.17M 148M 56.9M 725M 55.54M 54.32M 2.33B	12.66M 11.16M 10.55M 9.57M 17.97M 1.22B 18.13M 126M 48.71M 620M 47.54M 46.5M 1.99B